Home LiteratureArticle Details
PMID: 9696716 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Changes in G protein expression account for impaired modulation of hepatic cAMP formation after BDL.

The American journal of physiology ·Vol. 274 ·No. 6 ·1998-00-00 ·Pages G1151-9

Bouscarel B, Matsuzaki Y, Le M, Gettys TW, Fromm H

Abstract

The regulation of cAMP synthesis by hormones and bile acids is altered in isolated hamster hepatocytes 2 days after bile duct ligation (BDL) [Y. Matsuzaki, B. Bouscarel, M. Le, S. Ceryak, T. W. Gettys, J. Shoda, and H. Fromm. Am. J. Physiol. 273 (Gastrointest. Liver Physiol. 36): G164-G174, 1997]. Therefore, studies were undertaken to elucidate the mechanism(s) responsible for this impaired modulation of cAMP formation. Hepatocytes were isolated 48 h after either a sham operation or BDL. Both preparations were equally devoid of cholangiocyte contamination. Although the basal cAMP level was not affected after BDL, the ability of glucagon to maximally stimulate cAMP synthesis was decreased by approximately 40%. This decreased glucagon effect after BDL was not due to alteration of the total glucagon receptor expression. However, this effect was associated with a parallel 50% decreased expression of the small stimulatory G protein alpha-subunit (GsalphaS). The expression of either the large subunit (GsalphaL) or the common beta-subunit remained unchanged. The expression of Gialpha2 and Gialpha3 was also decreased by 25 and 46%, respectively, and was associated with the failure of ANG II to inhibit stimulated cAMP formation. Therefore, alterations of the expression of GsalphaS and Galphai are, at least in part, responsible for the attenuated hormonal regulation of cAMP synthesis. Because cAMP has been reported to stimulate both bile acid uptake and secretion, impairment of cAMP synthesis and bile acid uptake may represent an initial hepatocellular defense mechanism during cholestasis.

MeSH Terms
Angiotensin II/pharmacology Animals Cholestasis/metabolism Colforsin/pharmacology Common Bile Duct/surgery Cricetinae Cyclic AMP/biosynthesis GTP-Binding Protein alpha Subunits, Gi-Go/analysis,metabolism GTP-Binding Protein alpha Subunits, Gs/analysis,metabolism GTP-Binding Proteins/analysis,metabolism Glucagon/pharmacology Keratins/analysis Ligation Liver/drug effects,metabolism Male Mesocricetus Receptors, Glucagon/analysis Taurochenodeoxycholic Acid/pharmacology Ursodeoxycholic Acid/pharmacology
Chemicals
Receptors, Glucagon Angiotensin II Colforsin Taurochenodeoxycholic Acid ursodoxicoltaurine Keratins Ursodeoxycholic Acid Glucagon Cyclic AMP GTP-Binding Proteins GTP-Binding Protein alpha Subunits, Gi-Go GTP-Binding Protein alpha Subunits, Gs
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Bouscarel B
Department of Medicine, George Washington University Medical Center, Washington, District of Columbia 20037, USA.
Matsuzaki Y
Le M
Gettys T W
Fromm H
Article Info
Journal
The American journal of physiology
Abbr.
Am J Physiol
ISSN
0002-9513
Published
1998-00-00
Pages
G1151-9
Language
English
Region
United States
NLM ID
0370511
Subset
IM
Grants
NIDDK NIH HHS · DK-42486 · United States
NIDDK NIH HHS · DK-46954 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com